MedTrace Logo

Exploratory Study of Iocide Oral Rinse in a Diabetic Population

NCT00801164 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2012-02-02

No results posted yet for this study

Summary

The goals of this exploratory study are to 1)examine an investigational oral rinse as an adjunctive agent to scaling and root planing in treating chronic periodontitis in a periodontitis-susceptible diabetes population, and 2) evaluate its effect on glycemic control and biomarkers of systemic inflammation.

Conditions

  • Diabetes Type 2
  • Periodontitis

Interventions

DRUG

Frio Mouth Rinse Placebo

Prescription Mouth Rinse. Rinse with 15ml twice daily then expectorate.

DRUG

Frio Mouth Rinse

Prescription Mouth Rinse. Rinse with 15ml twice daily then expectorate.

Sponsors & Collaborators

  • Methodist Healthcare Ministries of South Texas

    collaborator UNKNOWN

  • Foundation Of Collaborative Unique Science (FOCUS)

    collaborator UNKNOWN

  • Biomedical Development Corporation

    lead INDUSTRY

Principal Investigators

  • Thomas W. Oates, DMD, Ph.D. · University of Texas

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
SINGLE_GROUP

Eligibility

Min Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2010-04-30
Completion
2010-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00801164 on ClinicalTrials.gov